Landscape Capital Management’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History

Landscape Capital Management’s Portfolio EBAC Stock Details EBAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,025	Closed	-$111K	–	966
2022 Q4	$111K	Hold	11,025	–	–	0.02%	705
2022 Q3	$109K	Hold	11,025	–	–	0.01%	870
2022 Q2	$108K	Hold	11,025	–	–	0.01%	862
2022 Q1	$107K	Buy	11,025 +100	+0.9%	+$972	0.01%	861
2021 Q4	$106K	Hold	10,925	–	–	0.01%	782
2021 Q3	$106K	Buy	+10,925	New	+$106K	0.01%	736

Landscape Capital Management's EBAC Position: Q1 2023 in Review

Landscape Capital Management sold out of European Biotech Acquisition Corp. Class A Ordinary Shares (EBAC) in Q1 2023, closing a stake of 11,025 shares — an estimated $111K sold.

Landscape Capital Management first reported a position in EBAC in Q3 2021 and held it in 6 quarters. The position peaked at $111K in Q4 2022. 0 funds tracked by Wall St. Rank hold EBAC as of Q1 2023.

Landscape Capital Management reported no remaining European Biotech Acquisition Corp. Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Landscape Capital Management sold 11,025 European Biotech Acquisition Corp. Class A Ordinary Shares shares in Q1 2023, an estimated $111K.
Landscape Capital Management first reported a position in European Biotech Acquisition Corp. Class A Ordinary Shares in Q3 2021 and held it in 6 quarters.
Landscape Capital Management's European Biotech Acquisition Corp. Class A Ordinary Shares position peaked at $111K in Q4 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Class A Ordinary Shares as of Q1 2023.

Based on Landscape Capital Management's 13F filing for Q1 2023, filed 10 May 2023.